Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term drug resistance. Found 23 abstracts

no pagination
Biswas A, Haldane A, Arnold E, Levy RM. Epistasis and entrenchment of drug resistance in HIV-1 subtype B. eLife. 2019 Oct 08;8.   PMCID: PMC6783267
Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshaysky A, Liu Y, Ross EA, El-Deiry WS. Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in oncology. 2019 Jan;8:652.   PMCID: PMC6344461
Ghatalia P, Smith CH, Winer A, Gou J, Kiedrowski LA, Slifker M, Saltzberg PD, Bubes N, Anari FM, Kasireddy V, Varshavsky A, Liu Y, Ross EA, El-Deiry WS. Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in oncology. 2018 Jan;8:652.   PMCID: PMC6344461
Wu D, Si M, Xue HY, Wong HL. Nanomedicine applications in the treatment of breast cancer: current state of the art. International journal of nanomedicine. 2017 Aug;12:5879-92.   PMCID: PMC5566389
Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene. 2003 Oct;22(47):7496-511.
Pan B, Yao KS, Monia BP, Dean NM, McKay RA, Hamilton TC, O'Dwyer PJ. Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype. Biochemical pharmacology. 2002 May;63(9):1699-707.
Ferry KV, Fink D, Johnson SW, Nebel S, Hamilton TC, Howell SB. Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells. Biochemical pharmacology. 1999 Apr 15;57(8):861-7.
Kaye SB, Eisenhauer EA, Hamilton TC. New non-cytotoxic approaches to ovarian cancer. Annals of Oncology. 1999 Jan;10:65-8.
Ranganathan S, Dexter DW, Benetatos CA, Hudes GR. Cloning and sequencing of human beta(III)-tubulin cDNA: induction of beta(III) isotype in human prostate carcinoma cells by acute exposure to antimicrotubule agents. Biochimica Et Biophysica Acta-Gene Structure and Expression. 1998 Jan 21;1395(2):237-45.
Sangrajrang S, Denoulet P, Laing NM, Tatoud R, Millot G, Calvo F, Tew KD, Fellous A. Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression. Biochemical pharmacology. 1998 Feb;55(3):325-31.
Shen HX, Schultz M, Kruh GD, Tew KD. Increased expression of DNA-dependent protein kinase confers resistance to adriamycin. Biochimica Et Biophysica Acta-General Subjects. 1998 Jul 23;1381(2):131-8.
Schultz M, Dutta S, Tew KD. Inhibitors of glutathione S-transferases as therapeutic agents. Advanced Drug Delivery Reviews. 1997 Jul 07;26(2-3):91-104.
Smith CD, Zilfou JT, Zhang XQ, Hudes GR, Tew KD. Modulation of P-Glycoprotein Activity by Estramustine Is Limited by Binding to Plasma-Proteins. Cancer. 1995 May 15;75(10):2597-604.
Zilfou JT, Smith CD. Differential Interactions of Cytochalasins with P-Glycoprotein. Oncology Research. 1995 Jan;7(9):435-43.
Johnson SW, Perez RP, Godwin AK, Yeung AT, Handel LM, Ozols RF, Hamilton TC. Role of Platinum-DNA Adduct Formation and Removal in Cisplatin Resistance in Human Ovarian-Cancer Cell-Lines. Biochemical pharmacology. 1994 Feb 11;47(4):689-97.
Joseph P, Sharma MC, Jaiswal AK. Inhibition of Nad(P)H-Quinone Oxidoreductase(1) in Ethacrynic Acid-Resistant Human Colon-Carcinoma Cells. Biochemical pharmacology. 1994 Jun;47(11):2011-5.
Devries EG, Hamilton TC, Lind M, Dauplat J, Neijt JP, Ozols RF. Drug-Resistance, Supportive Care and Dose Intensity. Annals of Oncology. 1993 Jan;4:57-62.
Johnson SW, Ozols RF, Hamilton TC. Mechanisms of Drug-Resistance in Ovarian-Cancer. Cancer. 1993 Jan 15;71(2):644-9.
Ozols RF, O'Dwyer PJ, Hamilton TC. Clinical reversal of drug resistance in ovarian cancer. Gynecologic Oncology. 1993 Jan;51(1):90-6.
Perez RP, Hamilton TC, Ozols RF, Young RC. Mechanisms and modulation of resistance to chemotherapy in ovarian cancer. Cancer. 1993 Jan;71(4 SUPPL.):1571-80.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term drug resistance

drug resistance cisplatin ovarian cancer cancer cells taxol resistance expression estramustine alkylating-agents repair p-glycoprotein beta-tubulin carcinoma melphalan ovary cancer binding tumor burden precision oncology gene-expression structural features buthionine sulfoximine carboplatin tumor heterogeneity liquid biopsy analogs drugs multidrug-resistance vinblastine alkylating agents gene molecular target drug-resistance glutathione-s-transferase isotypes mutations cis-diamminedichloroplatinum(ii) accumulation genes dt-diaphorase bone-marrow transplantation ethacrynic-acid multiple-drug colony-stimulating factor DNA-PK platinum cyclophosphamide chemotherapy diamminedichloroplatinum(ii) resistance MRP physics of living systems cyto-toxicity microtubule assembly invitro KeyWords Plus: reverse multidrug-resistance signal antisense reversal immunotherapy tubulin refractory ovarian- plasma proteins solid tumors vincristine depletion s-transferase activity acid antioxidant response element ethacrynic acid agent gene regulation ap-1 bovine brain sensitive cell-lines melphalan cyto-toxicity transporter prostate- cisplatin resistance HUMAN MDR1 GENE breast-cancer-cells adriamycin carcinoma cells 5'-FLANKING REGION ISIS 10582 cancer chemotherapy mdr MDR glycoprotein phase-i tubulin isotype computational biology genetic therapy prostatic cell lines monoclonal-antibody cos-1 cells lines drug-resistant liver hiv polyglutamylation epistasis ku-autoantigen cfDNA targeted delivery alkylating agent metalloproteinase inhibitors human-breast breast cancer c-Jun kinetic stabilization anticancer drugs nitrogen mustard-resistant chemotherapy cfdna human-tissues in-vitro P-GLYCOPROTEIN EXPRESSION cytochalasins BINDING-PROTEIN YB-1 glutathione modulation promoter alpha-tubulin colon carcinoma isotype expression evolution carcinoma cell-lines MULTIDRUG-RESISTANCE-1 GENE alpha-class adducts DNA mismatch repair transduction dna-binding virus acquired-resistance supportive care quinone oxidoreductase(1) proteins psc-833 accumulation nanomedicine tumor microenvironment mechanism DNA phenotype v(d)j recombination tolerance strand-break repair ethacrynic nad(p)h systems biology entrenchment human-tumor cells
Last updated on Thursday, July 02, 2020